Among patients with HBV-HCC and a low AFP level, the Cx43+ rate in the group with distant metastases was lower than that in patients with no metastases or liver-only metastases (both P < 0.05) (Table 4). This evidence concerns the gene GJA1 and hepatocellular carcinoma.